AXIM (AXIM Biotechnologies) Fixed Maturity Investment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is AXIM Biotechnologies Fixed Maturity Investment?

Fixed Maturity Investment only applies to insurance companies.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc. is a US-based research and development company focused on diagnostic healthcare solutions. It develops rapid diagnostic tests, with an emphasis on ophthalmological conditions such as Dry Eye Disease, and has also pursued research and intellectual property related to SARS-CoV-2 neutralizing antibody tests designed to measure functional antibody levels. The company's activities center on developing and commercializing point-of-care and rapid diagnostic products intended for use by healthcare providers and clinical settings. Its revenue model is based on the development, licensing, and potential commercialization of its diagnostic technologies and related intellectual property, though historically it has generated limited product revenue and has relied on financing to fund research and development. The company operates primarily in the United States.